Use of Conventional Phototherapy vs Light-Emitting Diode for the Treatment of Unconjugated Hyperbilirubinemia in Neonates: A Randomized Controlled Trial

传统光疗与发光二极管治疗新生儿非结合型高胆红素血症的随机对照试验

阅读:1

Abstract

Neonatal hyperbilirubinemia is a disease found in newborns, and it can lead to permanent brain damage. Unconjugated hyperbilirubinemia could be treated by using various phototherapy techniques. This study sought to compare the mean duration of treatment required with light-emitting diode (LED) versus conventional phototherapy in newborns with unconjugated hyperbilirubinemia. The investigation included 452 patients, randomly distributed into two groups. LED phototherapies were administered to Group 1, while conventional phototherapy was administered to Group 2. Total serum bilirubin levels, along with unconjugated serum bilirubin levels, were checked at baseline. Once the serum total bilirubin level fell below the cutoff level, phototherapy was stopped. The total duration of phototherapy, in hours, along with other demographic data, was recorded and subsequently analyzed using a Student's t-test. In Group 1, the mean gestational age was 37.51 ± 1.02 weeks, whereas in Group 2, it was 37.54 ± 1.02 weeks. The mean duration required for treatment with LED (Group 1) versus the conventional method of phototherapy (Group 2) in neonates with unconjugated jaundice was 36.26 ± 3.24 hours vs 45.5 ± 5.13 hours (p<0.0001), respectively. It was concluded that the mean duration required for the treatment of newborns affected by unconjugated hyperbilirubinemia was significantly lower with LED than with conventional phototherapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。